{"titles": ["\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u611f\u67d3\u7ecf\u7cbe\u5b50\u4f20\u64ad\u7684\u53ef\u80fd\u6027\u7814\u7a76", "Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice", "The role of interferon \u03b3 in regulation of CD4< sup>+</sup> T-cells and its clinical implications", "Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells", "Chimeric human papilloma virus\u2013simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques", "Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes", "Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors", "Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-\u03baB-mediated signalling, moderated by TGF-&bgr", "IL-10 mediates suppression of the CD8 T cell IFN-\u03b3 response to a novel viral epitope in a primed host", "BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions", "IFN-\u03b3 promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host", "Association of bovine papillomavirus type 1 with microtubules", "Manipulating IL-10 signalling blockade for better immunotherapy", "Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16", "Overcoming original antigenic sin to generate new CD8 T cell IFN-\u03b3 responses in an antigen-experienced host", "Development and function of IL-10 IFN-\u03b3-secreting CD4+ T cells", "Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: Immunological problems and future directions", "Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses", "Graphene oxide absorbed anti-IL10R antibodies enhance LPS induced immune responses in vitro and in vivo", "Crusted scabies is associated with increased IL\u201017 secretion by skin T cells", "Combination of immunotherapy with anaerobic bacteria for immunogene therapy of solid tumours", "Vaccine against scabies: necessity and possibility", "IL-10 signalling blockade at the time of immunization inhibits Human papillomavirus 16 E7 transformed TC-1 tumour cells growth in mice", "Host immune responses to the itch mite, Sarcoptes scabiei, in humans", "Targeting CD83 for the treatment of graft-versus-host disease", "\u8840\u7ba1\u7d27\u5f20\u7d20\u8f6c\u5316\u9176\u57fa\u56e0\u63d2\u5165/\u7f3a\u5931\u591a\u6001\u6027\u4e0e\u51a0\u72b6\u52a8\u8109\u75c5\u53d8", "Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirions", "\u5589\u4e73\u5934\u72b6\u7624\u60a3\u513f\u8840\u6e05\u4eba\u4e73\u5934\u72b6\u7624\u75c5\u6bd2 11b \u75c5\u6bd2\u6837\u9897\u7c92\u6297\u4f53\u68c0\u6d4b\u53ca\u610f\u4e49", "\u4eba\u4e73\u5934\u7624\u75c5\u6bd2 6b \u578b\u75c5\u6bd2\u6837\u9897\u7c92\u514d\u75ab\u6d3b\u6027\u7684\u7814\u7a76", "Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of Hydro-Phobic and Hydrophilic Residues to Inhibit IL-10", "Blocking IL-10 signalling at the time of immunization renders the tumour more accessible to T cell infiltration in mice", "\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u611f\u67d3\u5916\u5468\u8840\u5355\u4e2a\u6838\u7ec6\u80de\u7684\u7814\u7a76\u73b0\u72b6", "Inhibitory mechanism of peptides with a repeating hydrophobic and hydrophilic residue pattern on interleukin-10", "Therapeutic vaccination against cervical cancer-are we near?", "HPV6b \u75c5\u6bd2\u6837\u9897\u7c92\u514d\u75ab\u6cbb\u7597\u513f\u7ae5\u5589\u4e73\u5934\u72b6\u7624\u4e34\u5e8a\u521d\u6b65\u7814\u7a76", "[Immunogenicity study of HPV 6b virus-like particles].", "Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10", "Genital warts treatment: beyond imiquimod", "Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with\u00a0\u2026", "Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice", "\u542b HPV16E7 \u7684\u5d4c\u5408\u578b VLPs \u5f15\u53d1\u7ec6\u80de\u6eb6\u89e3\u53cd\u5e94", "\u6162\u6027\u4e59\u809d\u60a3\u8005\u75c5\u6bd2\u524d C \u533a\u7a81\u53d8\u682a\u611f\u67d3\u7684\u68c0\u6d4b\u4e0e\u610f\u4e49", "\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u53d7\u4f53\u7684\u7814\u7a76\u8fdb\u5c55", "\u03b1 \u5e72\u6270\u7d20\u6cbb\u7597\u6025\u6027\u8f93\u8840\u540e\u4e19\u578b\u809d\u708e\u7684\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c", "Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management", "Gene cloning and expression of hybrid HPV6b L1/16E7 protein in insect cells", "\u4f5b\u5c71\u5730\u533a\u5b58\u5728\u7ecf\u8f93\u8840\u4f20\u64ad\u75c5\u6bd2 (TTV) \u611f\u67d3", "\u4e01\u578b\u809d\u708e\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u8fd1\u5c55", "Iodine-125 labeled Australian frog tree host-defense peptides caerin 1.1 and 1.9 better inhibit human breast cancer cells growth than the unlabeled peptides. 125I-caerin 1.9\u00a0\u2026", "\u6c27\u5316\u77f3\u58a8\u7eb3\u7c73\u9897\u7c92\u5438\u9644\u7684 5-\u6c1f\u5c3f\u5627\u5576, \u6297\u4f53\u548c\u7ec6\u80de\u56e0\u5b50\u7684\u4f53\u5916\u751f\u7269\u6d3b\u6027\u7814\u7a76", "The cellular immune response to scabies in a porcine model", "Increased IL-17 secretion from \u03b3\u03b4-T cells associated with the development of crusted scabies", "\u9776\u5411\u6838\u5b9a\u4f4d\u5e8f\u5217 siRNA \u5bf9\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u5171\u4ef7\u95ed\u5408\u73af\u72b6 DNA \u590d\u5236\u7684\u6291\u5236\u4f5c\u7528", "Cervical Cancer-Associated Human Papillomavirus 16 E7 Oncoprotein Inhibits Induction of Anti-Cancer Immunity by a CD4+ T Cell Dependent Mechanism", "Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kB-mediated signalling, moderated by TGF-B", "IL-10 Mediates Suppression of the CD8 T Cell IFN-\u03b3. Response to a Novel Viral Epitope in a Primed Host", "Vaccines against Human Papillomavirus infection", "HPV 6b L1 Virus-like Particles Elicit Humoral Immunity in Mice", "Mucosal immune responses to chimeric papillomavirus like particles in mice", "\u542b HPV16 E7 \u7684\u5d4c\u5408\u578b VLPs \u901a\u8fc7 MHC-1 \u901a\u8def\u5f97\u5230\u5448\u9012", "TdT \u4ecb\u5bfc dUTP \u7f3a\u53e3\u672b\u7aef\u6807\u8bb0\u6280\u672f\u68c0\u6d4b\u809d\u7ec6\u80de\u764c\u51cb\u4ea1", "\u5316\u5b66\u589e\u5f3a\u53d1\u5149\u6cd5\u5feb\u901f\u68c0\u6d4b\u8840\u6e05\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u8868\u9762\u6297\u539f", "\u7528 PCR \u6280\u672f\u68c0\u6d4b HBV \u611f\u67d3\u7684\u5916\u5468\u8840\u5355\u4e2a\u6838\u7ec6\u80de\u4e2d\u7684 HBV mRNA", "\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u589e\u5f3a\u5b50\u7684\u7814\u7a76\u8fdb\u5c55", "HBsAg/IgM \u590d\u5408\u7269\u662f\u9884\u6d4b\u6025\u6027 HBV \u611f\u67d3\u6162\u6027\u5316\u7684\u6307\u6807", "\u611f\u67d3\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u7684\u5916\u5468\u8840\u5355\u4fe1\u6838\u7ec6\u80de\u7684\u7814\u7a76\u73b0\u72b6", "\u4e59\u578b\u809d\u708e\u75c5\u6bd2\u8bca\u65ad\u6280\u672f\u7684\u65b0\u8fdb\u5c55", "A skin graft model of immunotherapy for papillomavirus associated cervical cancer", "PARAS"], "ids": ["8c110335-9c9b-4e83-9619-9edd62cc8e57", "6c66b72a-2e5b-489a-8335-4d0931a3e0b3", "cae718b3-8664-4592-a2f1-568224d0f94b", "10ce54a3-9cda-4f18-9c1a-42a059aa7022", "063051d6-d436-4f08-ac0d-7024db081454", "a041114a-e5e7-42d6-86d0-336072fb2f06", "3e032a40-6637-4198-b1f0-401e2abdd81d", "a1d2973e-3b5c-493e-86b5-d96798e3e51f", "0aa96b3f-660e-40d2-bacd-dae7bfb20743", "c987b434-4c18-4d30-be8e-f22614a88f40", "86004906-77ba-4744-89c2-26133f6edf00", "ef5efd5d-cbe5-4cac-9ff7-5ccd457b9c27", "c052a52a-20ff-43a3-8f3c-ec2dd4bbf40b", "13ae38c2-220d-4a92-bb32-6bf4a882f4cf", "7856b08b-b278-4ea5-ae35-06603f280c66", "b4aa8baa-881b-45e3-9a5f-f7091d110d4b", "295b59c2-3e5d-486c-859c-dae64edf6ee3", "474238ad-ca12-4127-b01c-7b279c5fcbd6"]}